https://www.pfizer.com/news/press-release/press-release-detail/pfizer-receives-us-fda-emergency-use-authorization-novel Pfizer Receives U.S. FDA Emergency Use Authorization for Novel COVID-19 Oral Antiviral Treatment | Pfizer • PAXLOVID™ (nirmatrelvir [PF-07321332] tablets and ritonavir tablets) is authorized for emergency use in both high-risk adults and high-risk pediatric patients 12 years of..
https://www.france24.com/en/live-news/20210506-moderna-vaccine-96-percent-effective-in-12-17-year-olds-study-showsModerna vaccine 96 percent effective in 12-17 year-olds, study shows - France 24Moderna vaccine 96 percent effective in 12-17 year-olds, study showswww.france24.com모더나 코로나19 백신의 12세에서 17세에 대한 백신 임상테스트 결과가 나왔습니다. 3,235명참가 96%의 효과를 보여줬다고 합니다. 18세 이상에서 나온것과 비슷하게 2차 접종후 부작용 조금 있고 다 비스한거 ..
화이자는 FDA가 12-15세 용 코로나19 백신을 허가할 것 같다고 하네요. www.npr.org/sections/coronavirus-live-updates/2021/05/04/993519402/pfizer-says-fda-will-soon-authorize-covid-19-vaccine-for-12-15-age-group Pfizer Says FDA Will Soon Authorize COVID-19 Vaccine For 12-15 Age Group The company said in late March that clinical trials showed the vaccine elicits "100% efficacy and robust antibody responses" in adolescents. ..